InterventionsHuman trial
Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist in Participants with Type 2 Diabetes Mellitus Up to 32 Weeks
ADA Scientific Sessions 2025 Abstract
The paper
ZHAO J, ZHAO M, SONG W et al.
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Oral 126-OR